Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
sell

Gilead Sciences Inc sell Traumtanz

Gilead Sciences Inc
Start price
€66.80
20.05.20 / 50%
Target price
€60.00
25.05.20
Performance (%)
4.09%
End price
€69.53
25.05.20
Summary
This prediction ended on 25.05.20 with a price of €69.53. The SELL prediction by Traumtanz shows the price for Gilead Sciences Inc slightly increased by 4.09% during the runtime of the prediction. Traumtanz has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Gilead Sciences Inc -1.121% -1.121% -15.925% 10.352%
iShares Core DAX® 0.476% -0.039% 13.342% 17.330%
iShares Nasdaq 100 1.290% 0.504% 40.099% 50.534%
iShares Nikkei 225® 1.300% -2.135% 19.861% 4.937%
iShares S&P 500 0.829% 0.193% 29.756% 43.432%

According to Traumtanz what are the pros and cons of Gilead Sciences Inc for the foreseeable future?

Pros
Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Strong uniques
Small Risks for its business
Could be very worthwhile Investment >20% year
Cons

Comments by Traumtanz for this prediction

In the thread Gilead Sciences Inc diskutieren
Prediction Sell
Perf. (%) 4.09%
Target price 60.000
Change
Ends at 25.05.20

Sell mit Kursziel 60,0

Traumtanz 
0
Report Share
20.05.20
Traumtanz 
0
Report Share
20.05.20 Sell 4.09%

ValueFreak schrieb am 20.05.20: 
Naja, man klammert sich an jeden Strohhalm in der Krise
Bei den ersten acht Patienten
Das sieht mir noch nach einer langen Anlaufzeit aus - jeden Tag kommen 80.000 neu Infizierte hinzu und es ist noch kein globaler R-Wert von 1 erreicht.

https://www.fiercepharma.com/pharma/gilead-to-start-selling-remdesivir-coming-weeks-expects-multi-year-commercial-opportunity

30.ooo$ pro Behandlung scheint mir nicht gerade günstig...und selbst die anschliessend kolpotierten 4500$ pro Patient weisen in eine Zwei-Klassen-Medizin-Richtung...und ich wie immer skeptisch bei Gilead.

Traumtanz 
1
Report Share
20.05.20 Sell 4.09%

stratec schrieb am 20.05.20: 
ValueFreak schrieb am 20.05.20: 
Naja, man klammert sich an jeden Strohhalm in der Krise
Bei den ersten acht Patienten
Das sieht mir noch nach einer langen Anlaufzeit aus - jeden Tag kommen 80.000 neu Infizierte hinzu und es ist noch kein globaler R-Wert von 1 erreicht.

Ihr seid nicht auf dem Laufenden:

Sorrento claims it has COVID-19 cure


ah drum ging Sorrento so ab......aber dann...
 Sorrento shares have fallen about 50% from their highs on the news, perhaps raising questions in the market on what Sorrento actually has discovered drug wise. Also worth noting that like other emerging biotech companies, Sorrento isn’t profitable — which adds to the risk profile of the stock. ...
https://finance.yahoo.com/news/sorrento-therapeutics-founder-we-are-not-a-pump-and-dump-scheme-155253179.html

Traumtanz 
0
Report Share
20.05.20 Sell 4.09%
In the thread Trading Gilead Sciences Inc
Prediction Sell
Perf. (%) 4.09%
Target price 60.000
Change
Ends at 25.05.20

Sell beendet

Traumtanz 
0
Report Share
25.05.20

Stopped prediction by Traumtanz for Gilead Sciences Inc

buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€56.02
06.04.21
€60.00
06.04.22
3.82%
01.07.21

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
06.04.21 70%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€48.01
18.12.20
€45.00
-1.78%
23.12.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
18.12.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.30
14.11.20
-
14.11.21
-1.75%
23.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
14.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.60
13.11.20
€52.00
1.38%
14.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
13.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€50.00
09.11.20
€55.00
2.66%
10.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
09.11.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€49.75
31.10.20
-
04.11.21
0.53%
09.11.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
31.10.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€54.61
23.10.20
€55.00
31.10.20
-8.91%
31.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
23.10.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€51.42
20.10.20
€50.00
22.10.20
-1.26%
22.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
20.10.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.32
26.08.20
€50.00
08.10.20
-2.68%
08.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
26.08.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.59
19.08.20
€52.00
24.08.20
0.76%
24.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
19.08.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€67.00
20.06.20
€55.00
03.08.20
-10.91%
03.08.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
20.06.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.45
30.04.20
€85.00
04.05.20
-5.28%
04.05.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
30.04.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€74.99
04.04.20
-
18.04.20
5.08%
18.04.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
04.04.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€70.00
21.03.20
-
04.04.20
3.16%
04.04.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
21.03.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€76.81
19.03.20
€85.00
19.03.20
-3.91%
19.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
19.03.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€64.45
11.03.20
€55.00
11.03.20
0.51%
11.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
11.03.20 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€72.20
07.03.20
-
10.03.20
-13.56%
10.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
07.03.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€62.32
28.02.20
€58.00
07.03.20
9.27%
07.03.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
28.02.20 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€57.14
27.10.19
€50.00
03.02.20
6.00%
03.02.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
27.10.19 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€59.93
13.06.19
€45.10
07.08.19
-3.22%
07.08.19

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
05.08.19 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€58.18
13.05.19
€45.10
13.06.19
4.48%
13.06.19

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
05.08.19 50%
sell
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.99
25.04.19
€45.10
25.04.19
3.20%
25.04.19

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
05.08.19 50%
buy
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€77.35
03.02.16
€90.00
09.02.17
-18.07%
09.02.17

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Traumtanz 
05.08.19 50%